CMS 公布2026财年不当付款率:联邦医保7.32%涉339.6亿美元,医疗补助7.08%涉468.4亿美元,多为文件不足

美国医疗保险和医疗补助服务中心(CMS)11月16日发布情况说明,公布2026财年各主要计划的估计不当付款率。CMS 表示,不当付款指不符合计划要求的付款,包括多付、少付,以及信息不足以判断是否合规的付款;不当付款率并不衡量欺诈,其中一些可能涉及欺诈或滥用,另一些只是文件缺失或行政差错,例如州政府或承包商漏了一个必要的行政步骤,而补上这一步本可证明付款合规。
传统联邦医保(Original Medicare)2026财年的不当付款率为7.32%,约339.6亿美元,高于2025财年报告的6.55%、约288.3亿美元;CMS 指出,这是该数字连续第十年低于不当付款法规设定的10%合规门槛。Medicare C 部分(Medicare Advantage)的比率为5.68%,约238.6亿美元,低于上年的6.09%,其中大部分不当付款源于 Medicare Advantage 组织提交的支持文件无法证实其为付款申报的受益人诊断数据。Medicare D 部分(处方药计划)的比率为3.85%,约51.6亿美元,低于上年的4%,主要原因是计划主办方未能提供足够文件支持用于付款认定的处方数据。
医疗补助(Medicaid)的比率为7.08%,约468.4亿美元,高于2025财年的6.12%、约373.9亿美元;该估计由2024、2025、2026三年审查周期、每周期约17个州的数据合成,其中约79.41%的不当付款源于文件不足。儿童健康保险计划(CHIP)的比率为9.81%,约22.6亿美元,高于上年的7.05%,其中约55.93%源于文件不足。CMS 表示,医疗补助与 CHIP 估计值上升,部分原因是新冠疫情公共卫生紧急状态期间给予各州的灵活性措施逐步退出,例如资格重新认定与提供者重新验证要求已于2023年4月恢复。
此外,联邦交易所预付保费税收抵免(APTC)计划针对2024福利年度的2026财年不当付款率为0.84%,约8.3037亿美元,主要原因是自动错误造成的多付,其中多数与重复付款错误有关。
CMS 表示,本次测量的索赔期为2024年7月1日至2025年6月30日,早于该机构当前多项打击欺诈举措的实施,包括对高风险提供者类型(如家庭健康机构与临终关怀机构)暂停新注册、大规模撤销可疑账单模式提供者的注册并暂停付款,以及与各州和卫生与公众服务部监察长办公室协调的数据分析等;这些行动的影响预计将从2027财年数据开始显现,2028财年更明显。CMS 还在推进名为 ClaimsCore 的商业索赔处理现代化项目,把传统联邦医保的索赔处理迁移到安全、可配置的现代平台。
(来源:美国医疗保险和医疗补助服务中心)
CMS Reports FY 2026 Improper Payment Rates: Original Medicare 7.32% ($33.96 Billion), Medicaid 7.08% ($46.84 Billion), Mostly Insufficient Documentation
The Centers for Medicare & Medicaid Services (CMS) on Nov. 16 issued a fact sheet with its estimated improper payment rates for fiscal year 2026. CMS said an improper payment is a payment that does not meet program requirements, including overpayments, underpayments, and payments for which there is insufficient information to determine whether requirements were met. Improper payment rates do not measure fraud: while some improper payments may involve fraud or abuse, others reflect missing documentation or administrative errors, such as a state or contractor missing a required administrative step that would have established the payment was proper.
Original Medicare's FY 2026 improper payment rate was 7.32%, or $33.96 billion, compared with the FY 2025 reported rate of 6.55%, or $28.83 billion; CMS noted this marks the tenth consecutive year the figure has been below the 10% threshold for compliance established by improper payment statutory requirements. Medicare Part C's rate was 5.68%, or $23.86 billion, down from 6.09%, with most Part C improper payments attributable to Medicare Advantage organizations' documentation failing to substantiate beneficiary diagnosis data submitted for payment. Medicare Part D's rate was 3.85%, or $5.16 billion, down from 4%, mostly because plan sponsors failed to provide sufficient documentation to support prescription data used for payment determinations.
Medicaid's rate was 7.08%, or $46.84 billion, compared with 6.12%, or $37.39 billion, in FY 2025; the estimate is composed of the past three review cycles of approximately 17 states per cycle from reviews in 2024, 2025 and 2026, and about 79.41% of the improper payments resulted from insufficient documentation. The Children's Health Insurance Program (CHIP) rate was 9.81%, or $2.26 billion, up from 7.05%, with about 55.93% from insufficient documentation. CMS said the increases in the national Medicaid and CHIP estimates partly reflect the unwinding of flexibilities given to states during the COVID-19 public health emergency, such as eligibility redeterminations and provider revalidation requirements, which resumed in April 2023.
For the Advance Payments of the Premium Tax Credit (APTC) program for the Federally-Facilitated Exchange, the FY 2026 rate for benefit year 2024 was 0.84%, or $830.37 million, with the primary cause being overpayments from automated errors, most related to duplicate payment errors.
CMS said the FY 2026 measurements are based on claims submitted from July 1, 2024, through June 30, 2025, before many of its current anti-fraud initiatives were implemented, including Medicare enrollment moratoria for high-risk provider types such as home health agencies and hospices, large-scale provider enrollment revocations and payment suspensions targeting suspicious billing patterns, and greater use of advanced data analytics coordinated with states and the HHS Office of Inspector General. The agency expects the impact of these actions to begin appearing in FY 2027 data, with more substantial effects in FY 2028, and said it is also advancing ClaimsCore, a modernization of Original Medicare claims processing.
(Source: Centers for Medicare & Medicaid Services)
来源:美国医疗保险和医疗补助服务中心
发布:GSM·美国(发布链接)
图片来源:图:美国卫生与公众服务部总部大楼(资料照片)。GSM 联邦固定图库。 / Photo: U.S. Department of Health and Human Services headquarters (file photo). GSM federal asset library.
GSM Global · 本篇英文版 English edition of this story

